Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015-04 (PANGEA-Breast) study
帕博利珠单抗联合吉西他滨治疗HER2阴性晚期乳腺癌患者：GEICAM/2015-04 (PANGEA-Breast) 研究
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-022-10363-3
de la Cruz-Merino, L; Gion, M; Cruz, J; Alonso-Romero, J L; Quiroga, V; Moreno, F; Andrés, R; Santisteban, M; Ramos, M; Holgado, E; Cortés, J; López-Miranda, E; Cortés, A; Henao, F; Palazón-Carrión, N; Rodriguez, L M; Ceballos, I; Soto, A; Puertes, A; Casas, M; Benito, S; Chiesa, M; Bezares, S; Caballero, R; Jiménez-Cortegana, C; Sánchez-Margalet, V; Rojo, F
